Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach

Purpose: Sorafenib is the sole FDA approved drug conventionally used for the treatment of advanced hepatocellular carcinoma (HCC). Despite of the beneficial use of sorafenib in the treatment of HCC, multidrug resistance still remains a challenge. HCC is inherently known as chemotherapy resistant tum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Pharm Bull
Autors principals: Nair, Bhagyalakshmi, Anto, Ruby John, M, Sabitha, Nath, Lekshmi R.
Format: Artigo
Idioma:Inglês
Publicat: Tabriz University of Medical Sciences 2020
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335979/
https://ncbi.nlm.nih.gov/pubmed/32665908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34172/apb.2020.058
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars